Background {#Sec1}
==========

Syncope is a common condition in the pediatric population \[[@CR1]\]. The underlying cause of syncope is often benign and often explained by orthostatic intolerance or vasovagal reactions \[[@CR2], [@CR3]\]. However, some life-threatening diseases may present as syncope during childhood \[[@CR2], [@CR4], [@CR5]\].

Long QT syndrome (LQTS) is an uncommon genetic cardiac electrophysiological disorder in which altered ion channels within the myocytes cause prolonged repolarization \[[@CR6]\]. This alteration may induce Torsades de Pointes (TdP) and lethal ventricular tachyarrythmias \[[@CR7]\]. LQTS often presents as QT-prolongation and T-wave abnormalities on an electrocardiogram (ECG) \[[@CR6], [@CR8]\]. Congenital LQTS is an autosomal dominant hereditary disease caused by mutations in one or several known genes that regulate the function of ion channels of the myocytes \[[@CR9]\]. The most common types found in genotyped cases are mutations associated with LQT1, LQT2 and LQT3 \[[@CR6], [@CR10]\]. Genetic testing is available and a routine procedure in known families and is used in the evaluation of malignant syncope \[[@CR11]--[@CR13]\]. According to national guidelines, prophylactic treatment with propranolol is recommended for all children with LQTS in Sweden \[[@CR14]\].

The QT-interval in ECG is suggested to be adjusted to heart rhythm, QT-corrected time (QTc). In children 1--15 years of age, a QTc \> 440 ms is considered to be the borderline upper limit of the QTc interval, while QTc \> 460 ms is considered prolonged according to the national guidelines \[[@CR14]\]. Over 25% of genetically evident LQTS have a normal ECG, and 10--15% of the general adult population has a borderline QTc \[[@CR7], [@CR15]\]. Thus, ECG combined with medical and hereditary history is included in the evaluation of children at risk \[[@CR16], [@CR17]\]. Genetic testing is not first in line in patients with syncope admitted to the pediatric department. Life-threatening cardiac causes must be ruled out by ECG, exercise testing (EST) and/or 24-h ECG \[[@CR18]\]. EST and 24-h ECG are costly or not possible in younger children and/or are often associated with a long waiting list. There is a need for an easily available method when assessing malignant syncope in children \[[@CR19]\].

Postural changes are known to increase heart rate, heart rate variability and syncope \[[@CR20], [@CR21]\]. A significant change in QT-interval and QTc interval when standing is seen in adults with known LQTS compared to controls \[[@CR22], [@CR23]\]. An increase in QTc-interval among healthy children when standing has been shown in a few studies, indicating the need for more research \[[@CR24]--[@CR26]\]. No studies have compared QTc alterations in children with LQTS compared to healthy controls.

We hypothesized that a standing test could be valuable in the evaluation of QTc in children. Furthermore, we hypothesized that QTc measured while standing is prolonged in children with LQTS compared to otherwise healthy children.

Methods {#Sec2}
=======

Materials {#Sec3}
---------

This pilot case-control study included children between 1 and 18 years of age with genetically diagnosed LQTS attending the Pediatric Cardiology department at Östersund Hospital, Sweden. Two healthy cardiac controls matched by age and gender were randomly selected from the pediatric department while attending the clinic for other reasons.

Method {#Sec4}
------

A standard 12-lead ECG was conducted in a rested supine body position and followed by an ECG immediately after standing up. The children rested in the supine position for as long as needed for a reliable ECG. The ECG were conducted in a supine position and immediately followed by active standing. Information on age, height, weight, other medical conditions, medication, blood pressure, history of syncope or family members with known LQTS was retrieved for cases as well as controls. Drugs were stratified into four groups: 1) beta-blockers, 2) drugs that can cause QT prolongation or induce TdP, 3) other medications and 4) occasional medications. The "List of drugs to be avoided by congenital LQTS patients" available at [www.crediblemeds.org](http://www.crediblemeds.org) was used for classification.

ECG measures {#Sec5}
------------

*The* QT interval was manually measured predominantly in lead II or using other leads when the quality of lead II was low. The QT-interval was measured in milliseconds (ms) from the beginning of the QRS-complex to the end of the T-wave using the tangent method to locate the end of the T-wave \[[@CR27]\]. Bazett's formula was used for QTc calculations \[[@CR28]\]. QTc was measured for cases and controls in supine follow by a standing body position. Three medical doctors calculated QTc intervals individually, and two of these doctors were blinded with regard to case and control status as well as to body position. The mean QTc value was calculated between these separate measurements. A standing test using a cut-off value of 440 ms to define risk for LQTS was performed. Specificity and sensitivity were calculated for the standing test to identify LQTS cases among cases and controls.

Statistical analysis {#Sec6}
--------------------

Interobserver variability of ECG measurements was calculated using Cornbach's analysis. All data are presented as the mean (SD), median (range) or percentage (%) depending on the type and distribution of the data. Continuous data were primarily tested for normality using the Shapiro-Wilks test. Student's t-test (paired two-sided) was used for parametrically distributed variables within groups, One-way ANOVA between the groups, Repeated measures ANOVA for QTc changes and Person's X^2^ or Fisher's exact test for categorical data according to fit, with *p* \< 0.05 considered to be significant. All statistical analyses were performed using SPSS, version 25.

Results {#Sec7}
=======

Study-group demographics {#Sec8}
------------------------

Overall, 20 children were identified with LQTS at the pediatric cardiac departments. Two children were excluded due to incapacity to follow instructions due to young age and one declined participation, leaving 17 children to be included in the study (Fig. [1](#Fig1){ref-type="fig"}). Two cases were randomly matched to each case, including a total of 51 children in the study (17 cases and 34 controls). Fig. 1Study population

The mean age for cases was 9.0 years (±4.2 years), and for controls, 9,4 years (±4.2 years) and 76% of study participants were less than 12 years of age. There was no difference between cases and controls with regard to gender distribution, age, height, weight, history of syncope, other diseases or noncardiac medications (Table [1](#Tab1){ref-type="table"}). Treatment with beta-blockers, a lower blood pressure and a heredity for LQTS was more common among cases compared to controls (Table [1](#Tab1){ref-type="table"}). Table 1Population characteristics -- demographicsVariablesCases *N* = 17Controls *N* = 34*p*Weight mean (kg)35.0 (SD 22.3)38.8 (SD 20.8)0.552Height mean (cm)134.2 (SD 24.9)136.6 (SD 24.4)0.745Female n (%)9/17 (53%)18/34 (53%)1.00Male n (%)8/17 (47%)16/34 (47%)1.00Age mean (years)9.0 (SD 4.2)9,4 (SD 4.2)0.724Beta-blocker therapy n (%)17/17 (100%)0/34 (0%)\< 0.001Systolic BP mean (mm Hg)100.7 (SD 8.3)109.1 (SD 13.3)0.021Diastolic BP mean (mm Hg)56.0 (SD 10.5)69.8 (SD 12.2)\< 0.001Medications on LQTS avoid list n (%)4/17 (23.5%)3/34 (8.8%)0.203Other medications n (%)4/17 (23.5%)16/34 (47.0%)0.135Occasional medications n (%)3/17 (17.6%)12/34 (35.2%)0.328Heredity for LQTS n (%)17/17 (100%)0/34 (0%)\< 0.001History of syncope n (%)1/17 (5.8%)2/34 (5.8%)1.00Asthma n (%)6/17 (35%)6/34 (17%)0.181Diabetes n (%)0/17 (0%)5/34 (14.7%)0.156Other diseases n (%)3/17 (17.6%)9/34 (26.4%)0.728*BP* Blood pressure, *LQTS* Long-QT syndrome

QTc interval and body position {#Sec9}
------------------------------

Interobserver analysis of QTc measurements showed an interclass correlation level of 0.855 (*p* \< 0.001) for QTc in the supine position and 0.884 (*p* \< 0.001) for QTc in the standing position.

The mean QTc interval in the supine position was longer for cases (423.7 ms) compared to controls (391.4 ms) (*p* \< 0.001) (Table [2](#Tab2){ref-type="table"}, Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}). The QTc interval was longer for cases (443.5 ms) compared to controls (403.3 ms) (*p* \< 0.001) while standing (Table [2](#Tab2){ref-type="table"}, Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}), with a significant increase (Table [3](#Tab3){ref-type="table"}). There was no difference in QTc-interval change between cases and controls in the supine position compared with standing (*p* = 0.308) (Table [2](#Tab2){ref-type="table"}). A QTc interval of over 440 ms was calculated in four (24%) at the supine position and in eight (47%) while standing, but not in any of the controls (*p* = 0.003) (Table [2](#Tab2){ref-type="table"}). Table 2QTc compared between groupsQTc between groupsCase group (*N* = 17)Control group (*N* = 34)Difference*p*QTc in supine position mean (ms)423.7 (SD 27.4)391.4 (SD 22.4)32.3\< 0.001QTc in standing position mean (ms)443.5 (SD 39.5)403.3 (SD 21.3)40.2\< 0.001QTc change mean (ms)19.7 (SD 24.5)11.9 (SD 26.7)7.80.308QTc \> 440 m in supine position n (%)4/17 (23.6%)0/34 (0%)40.003QTc \> 440 m in standing position n (%)8/17 (47.0%)0/34 (0%)8\< 0.001*Ms* milliseconds, *SD* Standard deviationFig. 2Mean QTc change from supine body position to standing among cases and controlsFig. 3QTc median, range and percentiles of QTc for cases and controlsTable 3QTc compared within groupsQTc change within groupsSupine positionStanding positionDifference*p*Case group mean (ms)423.7(SD 27.4)443.5 (SD 39.5)19.7**0.004**Control group mean (ms)391.4 (SD 22.4)403.3 (SD 21.3)11.9**0.014***Ms* milliseconds, *SD* Standard deviationA significant change in QTc mean from supine to standing position for case- and control-group.

Standing test {#Sec10}
-------------

The standing test was able to identify LQTS at risk by ECG and reached a specificity of 100% and a sensitivity of 47.0%. The ability to identify a patient with LQTS on ECG while lying down reached a specificity of 100% and a sensitivity of 24% in our study.

Discussion {#Sec11}
==========

This pilot case-control study assessed the QTc interval in children with LQTS compared to healthy controls. An increased QTc-interval was present in children with LQTS in supine and standing body positions compared with controls. The standing test detected eight cases with prolonged QTc \> 440 ms, which was not observed in four of the children while in a supine position.

Prolongation of QTc-interval in children and testing {#Sec12}
----------------------------------------------------

A prolongation of QTc-interval in healthy children when standing is in line with other studies \[[@CR24], [@CR26]\]. According to the national guidelines, a QTc interval over 440 ms may indicate a risk of LQTS \[[@CR14]\]. A QTc \> 440 ms was observed in a large proportion of healthy children in other studies, while none of the healthy controls in our study presented a QTc \> 440 ms \[[@CR24], [@CR26]\]. The difference in the standing test method used in our study compared to other studies may explain the shorter QTc among controls in our study. The ECG standing was performed immediately after the ECG in the supine position, while others used a continuation of repeated ECG conducted at one-minute intervals \[[@CR24], [@CR26]\]. We chose to use this simpler method to better mimic a clinical setting at the emergency department where a simple standing test can be used in patients admitted to the ward for syncope. The QTc interval changes in children are mainly dependent on the increased heart rhythm while standing \[[@CR26]\]. One can speculate that the lack QTc increase in other studies in repeated ECG may have captured the maximum tachycardia level in healthy controls and LQTS patients with normal autonomic function, and QTc measurements in our study did not adjust the maximum heart rhythm \[[@CR26]\].

Our study indicates that the standing test with a sensitivity of 100% may rule out the risk of misclassifying a healthy child with LQTS. However, the specificity was only 47%, and a standing test will never be sufficient to confirm the diagnosis of LQTS. We believe that the standing test, together with other EST and 24-h ECG, may be used to evaluate which patients are likely to benefit from genetic screening. Furthermore, a standing test such as this is easy to perform and can be a useful tool in the selection of patients at risk.

Prolongation of QTc-interval in children; gender and age {#Sec13}
--------------------------------------------------------

Increased mean resting heart beat and a longer QTc interval are observed among premenopausal females, indicating that age as well as gender and hormonal levels influence electrophysical processes and characteristics \[[@CR29], [@CR30]\]. The standing test in adults provides diagnostic information as the QT interval increases in response to heart rate acceleration by standing \[[@CR22]\]. Age has been correlated with postural heart rate, as a higher heart rate does not indicate an increase in orthostatic intolerance \[[@CR31]\]. The study group in this study was young, predominantly in a prepubertal age group; 76% were under the age of 12. Information on growth and development, including Tanner stage, is missing in our study, and the study group was too small for age-specific calculations. Further studies on standing tests during different levels of growth may be helpful in discriminating borderline LQTS patients from healthy pre- and pubertal children.

Confounding factors, limitations and strength of the study {#Sec14}
----------------------------------------------------------

Cases had a lower systolic and diastolic blood pressure compared to controls (Table [1](#Tab1){ref-type="table"}). This discrepancy is likely due to the use of beta-blockers among cases \[[@CR32]\]. It is possible that beta-blockers may mask some of the QTc prolongation among children with LQTS. A majority of patients with LQTS are treated with beta-blockers, which is recommended by the national guidelines \[[@CR14]\]. Thus, it would be unethical to test QTc in LQTS patients without medications.

The controls were randomly selected and attended the pediatric department for other medical conditions and matched by age, gender and absence of heart disease. Matching two controls for each case increased the sample size and power of the study. There is a risk for selection bias, as our controls were visiting the hospital for other medical conditions that may influence the risk of prolonged QTc by the condition itself or by medication. There was no difference between cases and controls regarding age, gender, weight or medication other than beta-blockers; thus, we believe the risk of selection bias influencing our results is limited.

Conclusions {#Sec15}
===========

This pilot study shows significant differences in the QTc interval between children with LQTS and healthy controls in both the supine and standing positions, with a significantly prolonged interval in children with LQTS. With a standing test, we were able to detect a prolonged QTC interval in four cases, which was not present in these children while in a supine body position. These results suggest that there are significant differences between children with LQTS and healthy controls and that the use of a standing test could be valuable for the evaluation of syncope when suspecting LQTS.
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